Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRVSCRVS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CORVUS PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 1.6M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $23.6M as of 2026-Q2. The position was increased (+2.3% shares). CRVS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$23.6M

Current Shares

1.6M

Total Value Change

+$20.4M

Total Shares Change

+991,806

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+2.3%
$23.6M0.0%$14.94
29
2026-Q1
Increased
1.5M
+178.5%
$22.5M0.0%$17.53
46
2025-Q4
Increased
553,327
+24.2%
$4.3M0.0%$7.49
33
2025-Q3
Increased
445,670
+161.8%
$3.3M0.0%$7.28
43
2025-Q2
Decreased
170,211
-53.8%
$680,8440.0%$3.89
0
2025-Q1
Decreased
368,318
-37.0%
$1.2M0.0%$3.38
0
2024-Q4
New
584,546
-
$3.1M0.0%$5.25
37

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used